CV Therapeutics CEO in stock-trading plan with E-Trade
CV Therapeutics Inc. said Monday that its chairman and chief executive, Louis Lange, has entered a trading plan allowing for the sale of up to 50,000 common shares of the company. The Palo Alto, Calif., biopharmaceutical company said the trading plan signed Friday with a unit of E-Trade Financial Corp. replaces a trading plan that expired Saturday. In a filing with the Securities and Exchange
